Synapse - Dean Bajorin

Results (660)

Clinical outcome of patients with fibrosis/necrosis at post-chemotherapy retroperitoneal lymph node dissection for advanced germ cell tumors

Journal Article

Mano, R.; Becerra, M. F.; Carver, B. S.; Bosl, G. J.; Motzer, R. J.; Bajorin, D. F.; Feldman, D. R.; Sheinfeld, J.
Journal of Urology (2017)

Fulltext@MSK | Save

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: A single-arm, multicentre, phase 2 trial

Journal Article

Balar, A. V.; Galsky, M. D.; Rosenberg, J. E.; Powles, T.; Petrylak, D. P.; Bellmunt, J.; Loriot, Y.; Necchi, A.; Hoffman-Censits, J.; Perez-Gracia, J. L.; more...
Lancet (2017)

Fulltext@MSK | Save

Atezolizumab (atezo) as first-line (1L) therapy in cisplatin-ineligible locally advanced/metastatic urothelial carcinoma (mUC): Primary analysis of IMvigor210 cohort 1

Meeting Abstract

Balar, A. V.; Galsky, M. D.; Loriot, Y.; Dawson, N. A.; Necchi, A.; Srinivas, S.; Joseph, R. W.; Vaishampayan, U. N.; Sridhar, S. S.; Quinn, D. I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Differences in somatic DNA damage repair (DDR) gene alterations between primary and secondary muscle invasive bladder cancer (MIBC)

Meeting Abstract

Pietzak, E. J.; Bagrodia, A.; Li, Q.; Al-Ahmadie, H.; Herr, H. W.; Funt, S.; Barron, D.; Zehir, A.; Berger, M. F.; Solit, D. B.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

The role for resection of post-chemotherapy residual liver masses in the management of non-seminomatous germ cell tumor

Meeting Abstract

Pietzak, E. J.; Assel, M.; Tennenbaum, D. M.; Becerra, M.; Feldman, D. R.; Bajorin, D. F.; Motzer, R. J.; Bosl, G. J.; Carver, B. S.; Sjoberg, D.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations

Meeting Abstract

Pal, S. K.; Rosenberg, J. E.; Keam, B.; Wolf, J.; Berger, R.; Dittrich, C.; Hoffman-Censits, J. H.; Quinn, D.; van der Noll, R.; Burris, H. A.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

KEYNOTE-057: Phase 2 study of pembrolizumab for patients (pts) with Bacillus Calmette Guerin (BCG)-unresponsive, high-risk non-muscle-invasive bladder cancer (NMIBC)

Meeting Abstract

Kamat, A. M.; Bellmunt, J.; Choueiri, T. K.; Nam, K.; De Santis, M.; Dreicer, R.; Hahn, N. M.; Perini, R. F.; Siefker-Radtke, A. O.; Sonpavde, G.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Correlation of DNA damage response (DDR) gene alterations with response to neoadjuvant (neo) dose-dense gemcitabine and cisplatin (ddGC) in urothelial carcinoma (UC)

Meeting Abstract

Iyer, G.; Balar, A. V.; Milowsky, M. I.; Huang, W. C.; Woods, M.; Donat, S. M.; Herr, H. W.; Dalbagni, G.; Bochner, B. H.; Ostrovnaya, I.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Correlation of peripheral and intratumoral T-cell receptor (TCR) clonality with clinical outcomes in patients with metastatic urothelial cancer (mUC) treated with atezolizumab

Meeting Abstract

Funt, S.; Charen, A. S.; Yusko, E.; Vignali, M.; Benzeno, S.; Boyd, M. E.; Moran, M. M.; Kania, B. E.; Cipolla, C. K.; Regazzi, A. M.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save

Phase 2 trial results of DN24-02, a HER2-targeted autologous cellular immunotherapy in HER2+ urothelial cancer patients (pts)

Meeting Abstract

Bajorin, D. F.; Sharma, P.; Quinn, D. I.; Plimack, E. R.; Hoffman-Censits, J. H.; O'Donnell, P. H.; Siefker-Radtke, A. O.; Sheikh, N. A.; Lill, J. S.; Trager, J. B.; more...
Journal of Clinical Oncology (2016)

Fulltext@MSK | Save